Rhophylac Solution
Product Images NDC 44206-300

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rhophylac (NDC 44206-300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Csl Behring Ag, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (300 mcg Syringe Label)

Principal Display Panel (300 mcg Syringe Label)
Packaging label for Rhophylac 1500 IU solution containing Rho(D) Immune Globulin Intravenous (Human). The label indicates intramuscular and intravenous routes of administration, with a strength of 1500 IU. The product is labeled for prescription use only and manufactured by CSL Behring AG. The label includes dosing information and a barcode.*
FDA Label Image

Principal Display Panel (300 mcg Syringe Carton)

Principal Display Panel (300 mcg Syringe Carton)
Rhophylac 1500 IU solution for intravenous or intramuscular injection containing human Rho(D) immune globulin. Packaging label details include single-dose 2 mL syringes with 1500 IU (300 mcg) strength per syringe, manufactured by CSL Behring AG and distributed by CSL Behring LLC. The label states storage instructions and contents such as 10 prefilled syringes with SafetyGlide needles.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.